The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Advanced Bioscience Laboratories Inc

  • Advanced Bioscience Laboratories Inc

  • View government funding actions
  • Rockville, MD 208506386
  • Phone: 301-881-5445
  • Corporate URL: www.ablinc.com/
  • Estimated Number of Employees: 4,700
  • Estimated Annual Receipts: $1,535,562,039
  • Business Start Date: 1985
  • Contact Person: Fred Mack
  • Contact Phone: 301-816-5444
  • Contact Email: fred.mack@ablinc.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Foreign Owned and Located
  • For Profit Organization
  • Industries Served: In-Vitro Diagnostic Substance Manufacturing, Biological Product (except Diagnostic) Manufacturing, Testing Laboratories, Research and Development in Biotechnology, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
  • Product Areas: INSPECTION- REFRIGERATION, AIR CONDITIONING, AND AIR CIRCULATING EQUIPMENT, INSPECT SVCS/REFRIGERATION - AC EQ, MAINT/REPAIR/REBUILD OF EQUIPMENT- REFRIGERATION, AIR CONDITIONING, AND AIR CIRCULATING EQUIPMENT, MAINT-REP OF REFRIGERATION - AC EQ, MODIFICATION OF EQUIPMENT- REFRIGERATION, AIR CONDITIONING, AND AIR CIRCULATING EQUIPMENT, MOD OF REFRIGERATION - AC EQ, TECHNICAL REPRESENTATIVE- REFRIGERATION, AIR CONDITIONING, AND AIR CIRCULATING EQUIPMENT, TECH REP SVCS/REFRIGERATION - AC EQ, INSTALLATION OF EQUIPMENT- REFRIGERATION, AIR CONDITIONING, AND AIR CIRCULATING EQUIPMENT, INSTALL OF REFRIGERATION - AC EQ, INSTALLATION OF EQUIPMENT: VALVES, INSTALLATION OF EQUIPMENT- VALVES

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $80,219 - Monday the 1st of May 2017
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUSDISEASES
  • $770,532 - Wednesday the 29th of August 2012
    National Institutes Of Health
    NIH, NHLBI, DERA OA OFC ACQUISTIONS
    CONTRACT TITLE: SCIENCE MOVING TOWARDS RESEARCH AND TRANSLATION THERAPY (SMARTT)-BIOLOGICS PRODUCTION FACILITYCONTRACT TYPE: COST REIMBURSEMENT PLUS FIXED-FEE, MULTI-YEAR
  • $748,794 - Tuesday the 24th of April 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL RESEARCH
  • $748,794 - Monday the 3rd of December 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    OTHER FUNCTIONS - COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL RESEARCH
  • $727,388 - Monday the 1st of May 2017
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    1200005I ABL - VACCINE MCS - TASK 002 - $727,388 (MULT CANS) MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES
  • $654,068 - Monday the 3rd of December 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    OTHER FUNCTIONS - COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL RESEARCH
  • $644,727 - Monday the 2nd of April 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    NONHUMAN PRIMATE CORE QUANTITATIVE VIRAL RNA LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
  • $60,058 - Saturday the 1st of December 2012
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    IGF::OT::IGF (OTHER FUNCTIONS) ACCELERATED STABILITY TESTING OF SSP1 IMMUNOTOXIN DRUG PRODUCT
  • $5,796,117 - Friday the 19th of April 2013
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    IGF::OT::IGF - NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF THE MHRP GP145 CLADE C TRIMER PROTEIN
  • $420,000 - Friday the 22nd of February 2013
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    THE PURPOSE OF THIS MODIFIATION IS TO EXERCISE OPTION 2 YEAR 3 AND INCREMENTALLY FUND WITH FY12 FUNDS.

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.